Vanguard Global Advisers
NERV icon

Vanguard Global Advisers’s Minerva Neurosciences NERV Stock Holding History

Vanguard Global Advisers’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$85.1K Sell
15,335
-8,518
-36% -$46.2K ﹤0.01% 2847
2026
Q1 		$144K Buy
+23,853
New +$137K ﹤0.01% 2578

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ABG
Ally Bridge Group New York $113M AUM 245.92% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $643M AUM 343.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Global Advisers's NERV Position: Q2 2026 in Review

Vanguard Global Advisers reduced its Minerva Neurosciences (NERV) stake by 36% in Q2 2026, selling an estimated $46.2K and leaving 15,335 shares worth $85.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2847.

Vanguard Global Advisers first reported a position in NERV in Q1 2026 and has held it in 2 quarters since. The position peaked at $144K in Q1 2026. 59 funds tracked by Wall St. Rank hold NERV as of Q2 2026.

  • Vanguard Global Advisers held 15,335 shares of Minerva Neurosciences worth $85.1K as of Q2 2026.
  • Vanguard Global Advisers sold 8,518 Minerva Neurosciences shares in Q2 2026, an estimated $46.2K.
  • Minerva Neurosciences made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #2847 holding.
  • Vanguard Global Advisers first reported a position in Minerva Neurosciences in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Global Advisers's Minerva Neurosciences position peaked at $144K in Q1 2026.
  • 59 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.